Scientists develop 'smart' patch to administer insulin to diabetics

In an effort to better dispense insulin to diabetics, scientists at the University of North Carolina at Chapel Hill are developing a “smart” patch that will monitor blood glucose and release insulin when levels increase.

A study on the device, which has only been tested on mice so far, was published in the journal ACS Nano. Researchers hope the device will relieve diabetic patients of constantly having to prick themselves to check their glucose levels and administer insulin.

The patch sticks to the skin and is covered in painless microneedles that are loaded with insulin-carrying pouches. When glucose levels rise, the pouches break apart and release insulin into the patient.

The patch was effective when tested on mice and helped them maintain consistent concentrations of insulin in their blood.

“Insulin release responds quickly to elevated glucose and its kinetics can be modulated by adjusting the concentration of glucose oxidase loaded into the microneedles,” the authors wrote in the study. “Testing indicates that a single patch can regulate glucose levels effectively with reduced risk of hypoglycemia.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup